FORM 4

    
[__] Check this box if no
longer
subject to Section 16.  Form 4 or Form
5 obligations may
continue.

        See Instruction 1(b).

        


(Print or Type Responses)



     UNITED STATES SECURITIES
      AND EXCHANGE COMMISSION


    Washington,
D.C.  20549


      STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

      

      Filed pursuant to Section 16(a) of the Securities
      Exchange Act of 1934, Section 17(a) of the Public Utility

      Holding Company Act of 1935 or Section 30(h) of
      the Investment Company Act of 1940






    
OMB APPROVAL



	



    
OMB Number: 3235-0287

    
Expires: January 31,
2005
Estimated average burden
hours per response. . . . .
0.5













    
1. Name and Address of Reporting
Person*

      
   Astrom, Hakan 

    


    
(Last)    
                 (First)
                   
 (Middle)




    


        
  100 Route 206 North

      



    


    
(Street)




    


        
  Peapack, NJ 07977

      

    


    
(City)    
                 (State)
                   
 (Zip)










    
2. Issuer Name and Ticker

            or Trading Symbol



    
   Pharmacia - PHA

    


    
3. I.R.S.
Identification
    Number of
Reporting
    Person, if an
entity
    (voluntary)



     





    
4. Statement for


            (Month/Day/Year)

      


    
   01/02/2002

    


      
5. If Amendment,


            Date of Original


            (Month/Day/Year)



		
    

        





    
6. Relationship of Reporting
Person(s) to Issuer

    
(Check all
applicable)




      

              

          __   Director  
                                  
          __   10% Owner


        


           X    Officer (give title below)
            
          __   Other (specify below)


        


        
    Senior Vice President    

        

    


    
7. Individual or Joint/Group
Filing (Check Applicable Line)

    


      
  _ X _    Form filed by One Reporting Person

      


      
  ____    Form filed by

        More than One Reporting Person













    
Table I -
Non-Derivative Securities Acquired, Disposed of, or Beneficially
Owned









  

    

      
1. Title of
Security
    (Instr. 3)





    

      
2. Transaction
Date
    (Month/Day/Year)



    

      
2A. Deemed Execution
      Date,

        if any


              (Month/Day/Year)



    

      
3. Transaction Code


            (Instr. 8)


     
4.
Securities Acquired

      (A) or

            Disposed of (D)


          (Instr. 3, 4, and 5)



    

      
5. Amount of


            Securities


            Beneficially


            Owned


            Following
    Reported
    Transaction(s)


            (Instr. 3 and 4)



    

      
6. Ownership Form:


            Direct (D) or


            Indirect (I)


            (Instr. 4)



    

      
7. Nature of Indirect Beneficial


            Ownership


            (Instr. 4)




  
    Code
    V
    Amount
    (A) or (D)
    Price
  

           







  

     


      


      


  









    
Table II -
Derivative Securities Acquired, Disposed of, or Beneficially
Owned

    
(e.g., puts,
calls, warrants, options, convertible securities)









  

     
1. Title
of Derivative

        Security


            (Instr. 3)

     
2. Conver-


            sion or


            Exercise


            Price of


            Deri-


            vative


            Security

     
3. Transaction


            Date  (Month/


            Day/ Year)

     
3A. Deemed


              Execution Date,


              if any (Month/


              Day/ Year)

     
4.
Transaction Code

            


            (Instr.8)

     
5. Number
        of

            Derivative

            Securities Acquired 

            (A)

            or Disposed of (D)

            (Instr. 3, 4 and 5)
      

     
6. Date
Exercisable

        and


            Expiration Date


            (Month/Day/Year)

     
7. Title
and Amount


            of  Underlying


            Securities


            (Instr. 3 and 4)

     
8. Price of


            Derivative


            Security

            (Instr. 5)

     
9. Number of


            Derivative


            Securities


            Beneficially


            Owned


            Following 


            Reported


            Transaction(s)

            (Instr. 4)

     
10. Ownership


             Form of
     Derivative

             Securities:

             Direct (D)

             or

             Indirect (I)

             (Instr. 4)

     
11. Nature of


              Indirect


              Beneficial


              Ownership

              (Instr. 4)

  


Code
V
(A)
(D)
Date
Exercisable
Expiration
Date
Title
Amount or
Number of
Shares

Phantom Stock Units1 for 101/02/2002 
    A5
     15,170 //(1)//(2)Common15,170 16,269 (3)D 





  
    
Explanation
        of Responses:  (1) At the end of each calendar year
        2002, 2003 and 2004, 1/3 of the units will be eligible for allocation
        based on Company performance for that year.

             
     

             (2) Distribution under the plan commences
        the calendar year following retirement, termination, death or disability,
        based on the provisions of the Savings+Plus deferred compensation plan.

             
     
     (3) Includes dividends accrued in the form of phantom stock units. 

        

         
  
  
     
                  /s/ Don W. Schmitz for Hakan Astrom                 
       04/10/2003   
  
  
    ** Signature of
      Reporting Person
    Date 
    
  
  
    

      

      Reminder: Report on a separate line for each class of securities beneficially
      owned directly or indirectly.

      

      * If the form is filed by more than one reporting person, see Instruction
      4(b)(v).

      

      ** Intentional misstatements or omissions of facts constitute Federal Criminal
      Violations.

              See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

      

      Note:   File three copies of this Form, one of which must be manually
      signed. If space is insufficient,

                  See Instruction 6 for procedure.